Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action.

The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action. Abstract Text:

    margaret s leeMargaret S Lee,lisa johansenLisa Johansen,yanzhen zhangYanzhen Zhang,amy wilsonAmy Wilson,mitchell keeganMitchell Keegan,william averyWilliam Avery,peter elliottPeter Elliott,alexis a borisyAlexis A Borisy,curtis t keithCurtis T Keith,margaret s leeMargaret S Lee,lisa johansenLisa Johansen,yanzhen zhangYanzhen Zhang,amy wilsonAmy Wilson,mitchell keeganMitchell Keegan,william averyWilliam Avery,peter elliottPeter Elliott,alexis a borisyAlexis A Borisy,curtis t keithCurtis T Keith,

    Combination therapy has proven successful in treating a wide variety of aggressive human cancers. Historically, combination treatments have been discovered through serendipity or lengthy trials using known anticancer agents with similar indications. We have used combination high-throughput screening to discover the unexpected synergistic combination of an antiparasitic agent, pentamidine, and a phenothiazine antipsychotic, chlorpromazine. This combination, CRx-026, inhibits the growth of tumor cell lines in vivo more effectively than either pentamidine or chlorpromazine alone. Here, we report that CRx-026 exerts its antiproliferative effect through synergistic dual mitotic action. Chlorpromazine is a potent and specific inhibitor of the mitotic kinesin KSP/Eg5 and inhibits tumor cell proliferation through mitotic arrest and accumulation of monopolar spindles. Pentamidine treatment results in chromosomal segregation defects and delayed progression through mitosis, consistent with inhibition of the phosphatase of regenerating liver family of phosphatases. We also show that CRx-026 synergizes in vitro and in vivo with the microtubule-binding agents paclitaxel and vinorelbine. These data support a model where dual action of pentamidine and chlorpromazine in mitosis results in synergistic antitumor effects and show the importance of systematic screening for combinations of targeted agents.

    The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action. Publishing Authors By Initials

    ms leeMS Lee,l johansenL Johansen,y zhangY Zhang,a wilsonA Wilson,m keeganM Keegan,w averyW Avery,p elliottP Elliott,aa borisyAA Borisy,ct keithCT Keith,ms leeMS Lee,l johansenL Johansen,y zhangY Zhang,a wilsonA Wilson,m keeganM Keegan,w averyW Avery,p elliottP Elliott,aa borisyAA Borisy,ct keithCT Keith,

    For similar xenograft model antitumor assays research abstracts see: xenograft model antitumor assays research

    PUBMED ID PMID:

    MEDLINE DATE:

    The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Cancer research

    VOLUME: 67

    Page Numbers: 11359-67

    Journal Abbreviation: Cancer Res.

    ISSN: 1538-7445

    DAY: 1

    MONTH: Dec

    YEAR: 2007

    The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 2984705

    The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action. Keywords Mesh Terms:

    KEYWORDS: Xenograft Model Antitumor Assays

    MESH TERMS: analogs & derivatives

    Chemical & Substance for Abstract: The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action. Information

    Substance Name: Kinesin

    Registry Number: EC 3.6.1.-

    Grant and Affiliation Information for The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action.

    AFFILIATION: CombinatoRx, Incorporated, 245 First Street, 16th Floor, Cambridge, MA 02142, USA. mlee@combinatorx.com

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News